27 Years. 40+ Companies. One Vision: Transform Healthcare.
Radius Ventures (1997–2024) combined domain expertise with disciplined investing to drive innovation and strong returns.
About Radius Ventures
Founded in 1997 by Jordan S. Davis and Daniel C. Lubin, Radius Ventures was a venture capital firm focused on building category-defining companies in health and life sciences.
The firm operated from 1997 to 2024, successfully exiting its final investments during its last few years.
Over nearly two decades of active investing, the firm backed more than 40 venture-stage businesses, many of which achieved successful outcomes through initial public offerings or strategic acquisitions. Radius maintained a disciplined, domain-driven investment approach, supporting companies with the potential to transform patient care, improve health outcomes, and advance medical innovation.
Many of these exits not only delivered strong returns but also reshaped key segments across healthcare technology, diagnostics, and therapeutics. Radius’ disciplined investment approach and domain specialization earned the firm recognition as a leader in venture-stage healthcare investing. Its most recent and largest fund, Radius Venture Partner III, LP achieved top-quartile performance (Source: Cambridge Associates Q3 2024 Venture Capital Index and Benchmark Statistics).
Representative Portfolio Highlights
BioStorage Technologies
Acquired by Brooks Automation as a key component of its strategy to establish its leadership in biological specimen storage and biobanking, supporting precision medicine and pharmaceutical R&D.
Conor Medsystems
Conor Medsystems developed and commercialized innovative drug eluting stents to treat coronary artery disease. Conor completed its IPO in 2004 at $13 a share and was subsequently acquired by J&J for $1.4 billion or $33.50 a share in 2007.
Health Language
Acquired by Wolters Kluwer Health (WKH) as a pivotal enhancement to WKH’s strategy in medical terminology software and healthcare data analytics. This strategic move significantly bolstered Wolters Kluwer’s capabilities in providing comprehensive, interoperable solutions across the healthcare continuum.
Syft
Acquired by Global Health Exchange (GHX) as an integral component of its strategy to roll-up leading tech-enabled businesses engaged in digital healthcare supply chain management solutions. The Syft Synergy software platform is now core to GHX’s comprehensive solution for managing healthcare supply chains, focused on improving efficiency, visibility, and optimizing supply chains from Dock-to-Doc™ (i.e., from receiving goods to their final point of use).
Tactile Medical (Nasdaq: TCMD)
Tactile Medical is the leading provider of advanced at-home therapeutic devices for the treatment of lymphedema and chronic venous insufficiency. For over two years following its IPO in July 2016, Tactile ranked first in share price performance among commercial stage med-tech initial public offerings.
Tabula Rasa Healthcare
Tabula Rasa Healthcare (Now AnewHealth, following its 2023 merger with ExactCare Pharmacy and transition to private ownership) was a pioneering provider of medication risk mitigation technologies, with a focus on serving elderly populations through PACE (Programs of All-Inclusive Care for the Elderly) and managed care organizations. For over two years following its IPO in September 2016, Tabula Rasa ranked first in share price performance among commercial stage healthcare IT and services public offerings.
U-Systems
Acquired by GE Healthcare following FDA clearance of its somo-v® automated breast ultrasound system (rebranded by GE as Invenia™ ABUS), addressing a critical unmet need in breast cancer screening for women with dense breast tissue.
LEGACY LEADERSHIP TEAM
Highlighting the core leadership team that helped shape Radius Ventures from its founding in 1997 through its final chapter in 2024. While many talented individuals contributed to our journey, these were the enduring stewards of our investment strategy and portfolio success.
Jordan S. Davis
Managing Partner and Co-founder (1997 – 2024)
Known for his active investment approach, Jordan’s strategic input often led to game changing results. A connector, strategist, and company builder, he helped shape Radius’ identity as a hands-on, high-impact investment firm.
Daniel C. Lubin
Managing Partner and Co-Founder (1997 – 2024)
Dan’s unmatched network opened doors that transformed portfolio companies. Equally at ease with entrepreneurs and global leaders, Dan brought a rare mix of connectivity, conviction, and strategic insight that helped shape Radius’ platform and partnerships.
Neenah Jain
Chief Financial Officer (2008 - 2024)
Neenah was the backbone of Radius’ operations and a trusted steward in managing the firm’s finance, administrative and accounting operations.
VENTURE PARTNERS
Vincent S. Conti
Venture Partner (2010 - 2024)
A seasoned hospital executive, Vince brought steady judgment and operational insight to Radius companies, notably Syft and Healthsense. He previously served as President of Maine Medical Center.
James M. Mead
Venture Partner (2004 - 2024)
Jim brought a payor’s perspective, governance strength, and a powerful network to Radius, helping guide companies like Syft and Healthsense. He was formerly Vice Chairman, President and CEO of Capital BlueCross of Pennsylvania.
George M. Milne, Jr., Ph.D.
Venture Partner (2012 - 2024)
A probing and strategic thinker, George earned the deep trust of CEOs across the Radius portfolio, including BioStorage and Conor MedSystems. He previously served as Executive Vice President of Global R&D and President of Central Research at Pfizer.
IN MEMORIAM
We honor the memory of two exceptional colleagues who made significant contributions to our firm.
Floyd D. Loop, MD
Venture Partner (2005 - 2015)
A legendary heart surgeon and former Chairman and CEO of the Cleveland Clinic, Dr. Loop brought unmatched clinical vision and strategic insight to Radius during his decade as a Venture Partner.
Dr. Edward G. Murphy, MD
Operating Partner (2012 - 2017)
A respected physician-executive and former CEO of Carilion Clinic, Dr. Murphy played a pivotal role in the turnaround of Syft, offering disciplined leadership and lasting impact.
Moving forward
Jordan S. Davis
JSD Capital | Radius Special Situations
Daniel C. Lubin
Upsher Management Company
